Evolution of the Average Target: Stride, Inc.

Data source: Stride, Inc.(LRN)
Evolution of the Average Target - Stride, Inc.

Evolution of the Target Price: Stride, Inc.

Data source: Stride, Inc.(LRN)
Evolution of the Target Price - Stride, Inc.

Changes in Analyst Recommendations: Stride, Inc.

Data source: Stride, Inc.(LRN)
85476e0118b355dcc56de4.1V8QtM_JvpXFrw8tYjy80SNMxCh8p7cmL2ntsvsxubY.uTNhgaKj-tSLnEEaFQrlumB58AVF0s5TSByyxZRf946KKHfGhaSGx_XpNw~48d67871337f3f8fabbb3d823830d8e6
01/08 Stride Shares Fall After William Blair Downgrade MT
31/07 William Blair Downgrades Stride to Market Perform From Outperform MT
29/10/25 Morgan Stanley Lowers Price Target on Stride to $130 From $159, Keeps Equalweight Rating MT
29/10/25 BMO Capital Downgrades Stride to Market Perform From Outperform, Adjusts PT to $108 From $164 MT
06/10/25 Analyst recommendations: Micron, Nike, Stellantis, Microsoft, Newmont Corp… Zonebourse
29/08/25 Barrington Raises Price Target on Stride to $185 From $170, Keeps Outperform Rating MT
06/08/25 Morgan Stanley Raises Price Target on Stride to $159 From $148, Keeps Equalweight Rating MT
06/08/25 Stride Q4 revenue, adjusted EPS beat estimates RE
30/04/25 Barrington Research Adjusts Stride's Price Target to $170 From $150, Keeps Outperform Rating MT
30/04/25 Morgan Stanley Raises Price Target on Stride to $148 From $141, Keeps Equalweight Rating MT
22/04/25 Stride Positioned for 'Beat, Raise' in Fiscal Q3 Amid Strong Enrollments, Morgan Stanley Says MT
21/04/25 Morgan Stanley Raises Price Target on Stride to $141 From $117, Keeps Equalweight Rating MT
30/01/25 Barrington Adjusts Price Target on Stride to $140 From $130, Maintains Outperform Rating MT
23/10/24 Morgan Stanley Raises Price Target on Stride to $94 From $74, Keeps Equalweight Rating MT
21/08/24 Stride Shares Fall After Citigroup Downgrade MT
20/08/24 Citigroup Downgrades Stride to Neutral From Buy, Adjusts Price Target to $90 From $77 MT
08/08/24 Barrington Research Adjusts Stride's PT to $90 From $85, Keeps Outperform Rating MT
08/08/24 Canaccord Genuity Initiates Coverage on Stride With Buy Rating, $94 Price Target MT
31/07/24 Barrington Research Adjusts Stride's Price Target to $85 From $75, Keeps Outperform Rating MT
24/04/24 Morgan Stanley Raises Price Target on Stride to $70 From $65, Cites 'Solid Quarter,' Keeps Equalweight Rating MT
26/01/24 BMO Capital Adjusts Price Target on Stride to $72 From $71, Keeps Outperform Rating MT
25/01/24 Barrington Ups Price Target on Stride to $75 From $70 as Fiscal Q2 Results Surpass Estimates, Maintains Outperform Rating MT
25/01/24 Barrington Research Adjusts Stride's Price Target to $75 From $70, Maintains Outperform Rating MT
17/11/23 BMO Capital Adjusts Stride's Price Target to $67 From $57, Maintains Outperform Rating MT
17/11/23 Morgan Stanley Adjusts Price Target on Stride to $60 From $57, Maintains Equal-Weight Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+20.93%
+34.13%
+25.25%
+20.06%
+8.83%
+30.48%
- - +30.45%
+38.52%
- - -28.48%
Average +20.02%
Weighted average by Cap. +22.20%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
82.39USD
Average target price
107.50USD
Spread / Average Target
+30.48%
High Price Target
125.00USD
Spread / Highest target
+51.72%
Low Price Target
90.00USD
Spread / Lowest Target
+9.24%

Analyst Consensus Detail

Analyst consensus - Stride, Inc.

Consensus revision (last 18 months)

Consensus revision (last 18 months) - Stride, Inc.
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - Stride, Inc.